-
Because the consequence of missed pulmonary embolism (PEM) is so grave, it is essential to continue our evolution of tools which maximize diagnostic sensitivity, offer clinical expedience, and minimize risk for the patient.
-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
-
Despite previous positive reports and much lay enthusiasm, omega-3 fatty acid treatment did not prevent Crohn's disease relapse. (Arguments continue as to whether the correct usage should be "Crohn disease" or "Crohn's disease." Most of the literature seems to use the latter designation, and this review will do likewise.)
-
Cognitive impairment in the U.S. population without dementia is found in 22% of those over age 70. This is more than the number of those with Alzheimer's or other dementias alone, and needs to be recognized and addressed in our healthcare of this group.
-
Current use of antipsychotic medications by the elderly places them at increased risk for hospitalization for pneumonia.
-
12-lead ECG and lead II rhythm strip obtained from a 67-year-old man with new-onset shortness of breath.
-
-
A growing literature suggests that packed red blood cell (PRBC) transfusions are associated with adverse outcomes in a variety of patient populations, but the mechanisms behind the observed effects are not clear.
-
Investigators at St Paul's Hospital in Vancouver, BC, conducted a retrospective review of all ICU admissions between November 1998 and July 2003, to find all patients who were potential candidates for noninvasive ventilation (NIV) in the context of an exacerbation of COPD or acute cardiogenic pulmonary edema (CPE).
